Stephen Feanny

462 total citations
10 papers, 372 citations indexed

About

Stephen Feanny is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Stephen Feanny has authored 10 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Stephen Feanny's work include Eosinophilic Esophagitis (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). Stephen Feanny is often cited by papers focused on Eosinophilic Esophagitis (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). Stephen Feanny collaborates with scholars based in Canada, Israel and United States. Stephen Feanny's co-authors include Chaim M. Roifman, Philip M. Sherman, Isaac Melamed, Henry Levison, Joseph Reisman, Barry J. Zimmerman, F. John McLaughlin, Isaac Melamed, B. Zimmerman and Simon Forsyth and has published in prestigious journals such as The American Journal of Medicine, Journal of Allergy and Clinical Immunology and Journal of Inherited Metabolic Disease.

In The Last Decade

Stephen Feanny

10 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Feanny Canada 6 150 150 130 101 100 10 372
Manuela Latorre Italy 13 67 0.4× 388 2.6× 68 0.5× 129 1.3× 385 3.9× 44 573
S.M. Reinartz Netherlands 10 82 0.5× 205 1.4× 12 0.1× 191 1.9× 72 0.7× 19 348
É. Serrano France 13 233 1.6× 107 0.7× 40 0.3× 134 1.3× 96 1.0× 42 431
Giuseppina Rotiroti United Kingdom 10 92 0.6× 498 3.3× 43 0.3× 568 5.6× 148 1.5× 17 734
D Stoll France 11 179 1.2× 49 0.3× 35 0.3× 62 0.6× 50 0.5× 28 297
Franco Ameli Italy 11 113 0.8× 236 1.6× 11 0.1× 138 1.4× 127 1.3× 19 354
Stephen V. Early United States 9 99 0.7× 107 0.7× 13 0.1× 9 0.1× 88 0.9× 10 303
Moacyr Saffer Brazil 8 24 0.2× 153 1.0× 10 0.1× 172 1.7× 53 0.5× 19 293
Reza Amin Iran 10 58 0.4× 155 1.0× 29 0.2× 65 0.6× 102 1.0× 38 324
Ricardo Cardona Colombia 15 27 0.2× 225 1.5× 417 3.2× 305 3.0× 65 0.7× 73 761

Countries citing papers authored by Stephen Feanny

Since Specialization
Citations

This map shows the geographic impact of Stephen Feanny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Feanny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Feanny more than expected).

Fields of papers citing papers by Stephen Feanny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Feanny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Feanny. The network helps show where Stephen Feanny may publish in the future.

Co-authorship network of co-authors of Stephen Feanny

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Feanny. A scholar is included among the top collaborators of Stephen Feanny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Feanny. Stephen Feanny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Marwaha, Ashish, Stephen Feanny, Adelle Atkinson, et al.. (2021). Progressive decline of T and B cell numbers and function in a patient with CDC42 deficiency. Immunologic Research. 69(1). 53–58. 5 indexed citations
3.
4.
Cada, Michaela, et al.. (2014). Monocytosis in a patient with a novel GATA2 mutation. 2(2). 85–90. 2 indexed citations
5.
Melamed, Isaac, Stephen Feanny, Philip M. Sherman, & Chaim M. Roifman. (1991). Benefit of ketotifen in patients with eosinophilic gastroenteritis. The American Journal of Medicine. 90(3). 310–314. 114 indexed citations
6.
Melamed, Isaac, Stephen Feanny, Philip M. Sherman, & Chaim M. Roifman. (1991). Benefit of ketotifen in patients with eosinophilic gastroenteritis. The American Journal of Medicine. 90(1). 310–314. 43 indexed citations
7.
Zimmerman, Barry J., et al.. (1988). Allergy in asthma. Journal of Allergy and Clinical Immunology. 81(1). 63–70. 108 indexed citations
8.
Feanny, Stephen, Simon Forsyth, Mary Corey, Henry Levison, & B. Zimmerman. (1988). Allergic bronchopulmonary aspergillosis in cystic fibrosis: a secretory immune response to a colonizing organism.. PubMed. 60(1). 64–8. 33 indexed citations
9.
Zimmerman, Barry J., et al.. (1987). Prevalence of abnormalities found by sinus x-rays in childhood asthma: Lack of relation to severity of asthma. Journal of Allergy and Clinical Immunology. 80(3). 268–273. 47 indexed citations
10.
Feanny, Stephen, Sylvester H. Chuang, L. E. Becker, & Joe T.R. Clarke. (1986). Intracerebral paraventricular hyperdensities: A new CT sign in Krabbe globoid cell leukodystrophy. Journal of Inherited Metabolic Disease. 10(1). 24–27. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026